(Q41154395)

27 September 2017

1 reference

title

A cost-effective approach to the diagnosis and treatment of fibromyalgia (English)

1 reference

27 September 2017

0 references

McCain GA

1

1 reference

27 September 2017

1 May 1996

1 reference

Rheumatic Diseases Clinics of North America

27 September 2017

1 reference

27 September 2017

22

1 reference

27 September 2017

323-349

1 reference

27 September 2017

2

1 reference

Regional sympathetic blockade in primary fibromyalgia

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Electroacupuncture in fibromyalgia: results of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Zopiclone in the treatment of sleep abnormalities in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The natural history of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Treatment of fibrositis with fluoxetine hydrochloride (Prozac).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Fibromyalgia and major affective disorder: a controlled phenomenology and family history study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The impact of a meditation-based stress reduction program on fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Role of physical fitness training in the fibrositis/fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The concept of primary fibromyalgia (fibrositis): clinical value, relation and significance to other chronic musculoskeletal pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The relationship of alpha and delta EEG frequencies to pain and mood in ‘fibrositis’ patients treated with chlorpromazine and l-tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The clinical syndrome of fibrositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Imipramine for the treatment of fibrositis: a therapeutic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970275-1

7 January 2021

10.1016/S0889-857X(05)70275-1

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8860802